| Date Filed | Type | Description |
| 08/09/2023 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 45,000 options to buy
@ $4.58, valued at
$206.1k
|
|
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2022 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Sold 10,297 shares
@ $0.19, valued at
$2k
|
|
| 08/18/2021 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 21,000 options to buy
@ $5.97, valued at
$125.4k
|
|
| 07/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/20/2020 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 10,500 options to buy
@ $9.13, valued at
$95.9k
|
|
| 09/06/2019 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 21,000 options to buy
@ $21.03, valued at
$441.6k
|
|
| 09/06/2019 |
3
| CORRIGAN MARK (Director) has filed a Form 3 on Wave Life Sciences Ltd. |
| 08/01/2019 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Granted 35,000 options
@ $0 |
|
| 08/13/2018 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 05/04/2018 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Granted 29,000 options
@ $0 |
|
| 09/19/2017 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Granted 10,100 options
@ $0 |
|
| 06/27/2017 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Nabriva Therapeutics Plc|
Txns:
| Acquired 20,200 options
@ $0
Acquired 10,100 options
@ $0 |
|
| 04/11/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 03/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/31/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/30/2016 |
3
| CORRIGAN MARK (Director) has filed a Form 3 on Nabriva Therapeutics AG |
| 05/12/2016 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Granted 8,897 options to buy
@ $6.24, valued at
$55.5k
|
|
| 10/29/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2015 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 9,000 options to buy
@ $6.39, valued at
$57.5k
|
|
| 01/21/2015 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Disposed of 7,501 shares
@ $102, valued at
$765.1k
Disposed/sold 16,519 options to buy
@ $21.01, valued at
$347.1k
Disposed/sold 9,472 options to buy
@ $38.06, valued at
$360.5k
Disposed/sold 9,367 options to buy
@ $41.2, valued at
$385.9k
Disposed/sold 8,370 options to buy
@ $50.24, valued at
$420.5k
Disposed/sold 6,202 options to buy
@ $66.68, valued at
$413.5k
Disposed/sold 1,687 restricted stock units
@ $0 |
|
| 07/17/2014 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 14,597 shares
@ $11.8, valued at
$172.2k
|
|
| 06/05/2014 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Granted 899 shares
@ $0
Granted 6,202 options to buy
@ $66.68, valued at
$413.5k
Granted 1,687 restricted stock units
@ $0
Exercised 1,104 restricted stock units
@ $0 |
|
| 02/28/2014 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Sold 5,000 shares
@ $80, valued at
$400k
Exercised 5,000 options to buy
@ $18.22, valued at
$91.1k
|
|
| 02/12/2014 |
4
| CORRIGAN MARK (President & CEO) has filed a Form 4 on Zalicus Inc.|
Txns:
| Granted 250,000 shares
@ $0
Granted 250,000 options to buy
@ $1.47, valued at
$367.5k
|
|
| 01/17/2014 |
4
| CORRIGAN MARK (President & CEO) has filed a Form 4 on Zalicus Inc.|
Txns:
| Paid exercise price by delivering 18,079 shares
@ $1.66, valued at
$30k
|
|
| 01/07/2014 |
4
| CORRIGAN MARK (President & CEO) has filed a Form 4 on Zalicus Inc.|
Txns:
| Paid exercise price by delivering 8,035 shares
@ $1.22, valued at
$9.8k
|
|
| 06/14/2013 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Granted 995 shares
@ $0
Granted 8,370 options to buy
@ $50.24, valued at
$420.5k
Granted 1,104 restricted stock units
@ $0 |
|
| 06/11/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|